» Articles » PMID: 27687525

Microglia Energy Metabolism in Metabolic Disorder

Overview
Date 2016 Oct 1
PMID 27687525
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Microglia are the resident macrophages of the CNS, and are in charge of maintaining a healthy microenvironment to ensure neuronal survival. Microglia carry out a non-stop patrol of the CNS, make contact with neurons and look for abnormalities, all of which requires a vast amount of energy. This non-signaling energy demand increases after activation by pathogens, neuronal damage or other kinds of stimulation. Of the three major energy substrates - glucose, fatty acids and glutamine - glucose is crucial for microglia survival and several glucose transporters are expressed to supply sufficient glucose influx. Fatty acids are another source of energy for microglia and have also been shown to strongly influence microglial immune activity. Glutamine, although possibly suitable for use as an energy substrate by microglia, has been shown to have neurotoxic effects when overloaded. Microglial fuel metabolism might be associated with microglial reactivity under different pathophysiological conditions and a microglial fuel switch may thus be the underlying cause of hypothalamic dysregulation, which is associated with obesity.

Citing Articles

Pathology and Treatments of Alzheimer's Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes.

Yanai H, Adachi H, Hakoshima M, Katsuyama H Molecules. 2025; 29(24.

PMID: 39770025 PMC: 11677283. DOI: 10.3390/molecules29245936.


An acute microglial metabolic response controls metabolism and improves memory.

Drougard A, Ma E, Wegert V, Sheldon R, Panzeri I, Vatsa N Elife. 2024; 12.

PMID: 39625057 PMC: 11614388. DOI: 10.7554/eLife.87120.


Fueling neurodegeneration: metabolic insights into microglia functions.

Sadeghdoust M, Das A, Kaushik D J Neuroinflammation. 2024; 21(1):300.

PMID: 39551788 PMC: 11571669. DOI: 10.1186/s12974-024-03296-0.


Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease.

Shippy D, Evered A, Ulland T Immunol Rev. 2024; 329(1):e13365.

PMID: 38989642 PMC: 11724017. DOI: 10.1111/imr.13365.


Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease.

Gedam M, Zheng H Eur J Immunol. 2024; 54(8):e2350815.

PMID: 38778507 PMC: 11305912. DOI: 10.1002/eji.202350815.